|Articles|September 27, 2017
Metrics Used at Carolina Blood and Cancer Care for OCM Reporting
Dr. Patel explains the metrics tracked at Carolina Blood and Cancer Care and identifies how these informed their understanding of patient care.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
3
ACO-SWITCH to Evaluate Tafamidis-to-Acoramidis Switch in ATTR-CM
4
FAQ: Prior Authorization Reform—Will Changes Go Far Enough by 2027?
5